IDEAS home Printed from https://ideas.repec.org/r/bla/biomet/v64y2008i4p1146-1154.html
   My bibliography  Save this item

Evaluating Candidate Principal Surrogate Endpoints

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Zhichao Jiang & Peng Ding & Zhi Geng, 2016. "Principal causal effect identification and surrogate end point evaluation by multiple trials," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 78(4), pages 829-848, September.
  2. Gilbert Peter B. & Hudgens Michael G. & Wolfson Julian, 2011. "Commentary on "Principal Stratification -- a Goal or a Tool?" by Judea Pearl," The International Journal of Biostatistics, De Gruyter, vol. 7(1), pages 1-15, September.
  3. Denis Agniel & Layla Parast, 2021. "Evaluation of longitudinal surrogate markers," Biometrics, The International Biometric Society, vol. 77(2), pages 477-489, June.
  4. Corwin M. Zigler & Thomas R. Belin, 2012. "A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate Endpoint," Biometrics, The International Biometric Society, vol. 68(3), pages 922-932, September.
  5. Emily K. Roberts & Michael R. Elliott & Jeremy M. G. Taylor, 2023. "Solutions for surrogacy validation with longitudinal outcomes for a gene therapy," Biometrics, The International Biometric Society, vol. 79(3), pages 1840-1852, September.
  6. Ghosh, Debashis, 2012. "A causal framework for surrogate endpoints with semi-competing risks data," Statistics & Probability Letters, Elsevier, vol. 82(11), pages 1898-1902.
  7. Gilbert Peter B. & Gabriel Erin E. & Huang Ying & Chan Ivan S.F., 2015. "Surrogate Endpoint Evaluation: Principal Stratification Criteria and the Prentice Definition," Journal of Causal Inference, De Gruyter, vol. 3(2), pages 157-175, September.
  8. Tyler J. VanderWeele, 2013. "Rejoinder," Biometrics, The International Biometric Society, vol. 69(3), pages 577-581, September.
  9. Ariel Alonso & Wim Van der Elst & Geert Molenberghs & Marc Buyse & Tomasz Burzykowski, 2015. "On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints," Biometrics, The International Biometric Society, vol. 71(1), pages 15-24, March.
  10. Ying Huang & Aliasghar Tarkhan, 2020. "Methods for Feature Selection in Down-Selection of Vaccine Regimens Based on Multivariate Immune Response Endpoints," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 12(3), pages 353-375, December.
  11. Michael R. Elliott & Anna Conlon & Yun Li, 2013. "Discussion on “Surrogate Measures and Consistent Surrogates”," Biometrics, The International Biometric Society, vol. 69(3), pages 565-569, September.
  12. Michael G. Hudgens & Peter B. Gilbert, 2009. "Assessing Vaccine Effects in Repeated Low-Dose Challenge Experiments," Biometrics, The International Biometric Society, vol. 65(4), pages 1223-1232, December.
  13. Layla Parast & Lu Tian & Tianxi Cai, 2020. "Assessing the value of a censored surrogate outcome," Lifetime Data Analysis: An International Journal Devoted to Statistical Methods and Applications for Time-to-Event Data, Springer, vol. 26(2), pages 245-265, April.
  14. Ying Huang, 2018. "Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling," Biometrics, The International Biometric Society, vol. 74(1), pages 27-39, March.
  15. Ying Huang & Shibasish Dasgupta, 2019. "Likelihood-Based Methods for Assessing Principal Surrogate Endpoints in Vaccine Trials," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 11(3), pages 504-523, December.
  16. Marshall M. Joffe, 2013. "Discussion on “Surrogate Measures and Consistent Surrogates”," Biometrics, The International Biometric Society, vol. 69(3), pages 569-573, September.
  17. Erin E. Gabriel & Michael C. Sachs & Dean A. Follmann & Therese M‐L. Andersson, 2020. "A unified evaluation of differential vaccine efficacy," Biometrics, The International Biometric Society, vol. 76(4), pages 1053-1063, December.
  18. Bartolucci, Francesco & Grilli, Leonardo, 2011. "Modeling Partial Compliance Through Copulas in a Principal Stratification Framework," Journal of the American Statistical Association, American Statistical Association, vol. 106(494), pages 469-479.
  19. Ying Huang & Peter B. Gilbert, 2011. "Comparing Biomarkers as Principal Surrogate Endpoints," Biometrics, The International Biometric Society, vol. 67(4), pages 1442-1451, December.
  20. Tomer Hertz & Hasan Ahmed & David P Friedrich & Danilo R Casimiro & Steven G Self & Lawrence Corey & M Juliana McElrath & Susan Buchbinder & Helen Horton & Nicole Frahm & Michael N Robertson & Barney , 2013. "HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1," PLOS Pathogens, Public Library of Science, vol. 9(6), pages 1-14, June.
  21. Peng Ding & Jiannan Lu, 2017. "Principal stratification analysis using principal scores," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 79(3), pages 757-777, June.
  22. Gilbert Peter B. & Blette Bryan S. & Shepherd Bryan E. & Hudgens Michael G., 2020. "Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial," Journal of Causal Inference, De Gruyter, vol. 8(1), pages 54-69, January.
  23. Zhichao Jiang & Shu Yang & Peng Ding, 2022. "Multiply robust estimation of causal effects under principal ignorability," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 84(4), pages 1423-1445, September.
  24. Julian Wolfson & Peter Gilbert, 2010. "Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials," Biometrics, The International Biometric Society, vol. 66(4), pages 1153-1161, December.
  25. Ying Huang & Peter B. Gilbert & Julian Wolfson, 2013. "Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials," Biometrics, The International Biometric Society, vol. 69(2), pages 301-309, June.
  26. Gilbert Peter B. & Blette Bryan S. & Hudgens Michael G. & Shepherd Bryan E., 2020. "Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial," Journal of Causal Inference, De Gruyter, vol. 8(1), pages 54-69, January.
  27. Tyler J. VanderWeele, 2013. "Surrogate Measures and Consistent Surrogates," Biometrics, The International Biometric Society, vol. 69(3), pages 561-565, September.
  28. Layla Parast & Tianxi Cai & Lu Tian, 2023. "Testing for heterogeneity in the utility of a surrogate marker," Biometrics, The International Biometric Society, vol. 79(2), pages 799-810, June.
  29. Layla Parast & Tanya P. Garcia & Ross L. Prentice & Raymond J. Carroll, 2022. "Robust methods to correct for measurement error when evaluating a surrogate marker," Biometrics, The International Biometric Society, vol. 78(1), pages 9-23, March.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.